Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
about
Redox regulation of FoxO transcription factorsInterplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogrammingSirtuins, metabolism, and DNA repairSirtuins in epigenetic regulationSestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signalingPhysiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.Sirtuins: guardians of mammalian healthspan.Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 CellsSirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cellsTwo tagSNPs rs352493 and rs3760908 within SIRT6 Gene Are Associated with the Severity of Coronary Artery Disease in a Chinese Han Population.FoxO3 transcription factor and Sirt6 deacetylase regulate low density lipoprotein (LDL)-cholesterol homeostasis via control of the proprotein convertase subtilisin/kexin type 9 (Pcsk9) gene expressionChromatin and beyond: the multitasking roles for SIRT6FoxO4 interacts with the sterol regulatory factor SREBP2 and the hypoxia inducible factor HIF2α at the CYP51 promoter.SIRT1 and other sirtuins in metabolism.Sirtuins in glucose and lipid metabolism.FOXO transcription factors protect against the diet-induced fatty liver disease.MicroRNAs in heart failure: Non-coding regulators of metabolic function.Clinically Relevant Mechanisms of Lipid Synthesis, Transport, and Storage.SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.Fabp4-Cre-mediated Sirt6 deletion impairs adipose tissue function and metabolic homeostasis in mice.Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming.SIRT6: Novel Mechanisms and Links to Aging and Disease.SIRT6 promotes osteogenic differentiation of mesenchymal stem cells through BMP signaling.A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2.Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome.SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.Sirtuin 6, a possible therapeutic target for type 2 diabetes.A Review of the Recent Advances Made with SIRT6 and its Implications on Aging Related Processes, Major Human Diseases, and Possible Therapeutic Targets
P2860
Q26799843-09F26B0F-EB04-4F02-B7A8-5A38679047A0Q26991931-F5EE3B48-EF8A-4B7E-A29F-5B3E02AFD262Q27015759-D78CF887-CFDE-4E25-9618-08DD2D24E20DQ27026861-A23AA590-31DD-4A60-B55E-6C5D6DDBA9A0Q28513222-BB6835DE-003B-47D3-B50E-6CBCD0B5427EQ33599961-79A9D360-D12A-473B-ABEE-57963F173406Q33831420-CFEF327C-8953-4C53-A0DA-549003CF6573Q35648897-FD1EB180-DCC2-46F6-BA9F-4C0FE9D8D5CCQ36129786-400ED3BC-33DE-4A03-9BEF-8160842C4566Q36689434-DCEFBFB4-13D8-4896-8CDF-9B495481CE38Q36784802-E70D1F63-7DCD-45BE-B803-1262393DC1EBQ37226067-C6645E23-C563-4952-90CC-84270D8DCA37Q37549637-CE17732E-75D7-467C-B6EA-C5BB6927BA8EQ37603216-3D7D6C9E-A057-4B72-A613-83A6BBCC4DB0Q37619655-86B90E5B-8885-4E11-BCC4-1340A6CF1812Q37702189-8DCB6913-D7FC-42AF-8D34-A16F6B53E5F2Q37704641-55255714-0598-499D-8116-FFBE436DD100Q37733659-F2DF22E9-227A-4BA9-98A8-385768E1FD1AQ38549782-CE296314-0A66-43E5-9D67-2DBC94466477Q38665115-E2853398-23F1-40DA-8679-09BD7286B647Q38849175-4A4E42A4-C096-4068-9BC1-99567AB59F4FQ38885481-C4B18750-2FF4-4237-A58C-485E9915A358Q39005741-8EDFCF4A-BAE2-4837-8571-9DB26D67B2AEQ40501228-7F5AB679-1023-4BCD-86FE-138E3413772AQ41551699-505A5CF6-1292-4619-B97E-8920E3FAC2A7Q41661616-308657D6-5B40-4A6F-8C0D-191130A0A4ADQ46484710-7D02AA92-0AF6-47B1-8FD3-5DDAEE60D250Q47692117-2733DBEA-F023-4E9A-BCC8-65ED2BCFA2DBQ49608860-2B06B653-8345-4A76-ABB6-D91F00675BF8Q57929129-708883BE-4A5D-4CF1-9BC7-B6A6E5993E44
P2860
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
@en
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6.
@nl
type
label
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
@en
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6.
@nl
prefLabel
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
@en
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6.
@nl
P2093
P2860
P356
P1476
Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
@en
P2093
Chu-Xia Deng
Ronald A DePinho
Rongya Tao
X Charlie Dong
Xiwen Xiong
P2860
P304
P356
10.1194/JLR.M039339
P577
2013-07-23T00:00:00Z